Document is current
Any future updates will be listed below
-
Authors
Zhang, Junqi
Yin, Wenhao
Jiang, Qingyuan
Mao, Wuxiang https://orcid.org/0000-0001-7213-3062
Deng, Wenwen
Jin, Shuqi
Wang, Xinping
He, Ruyi
Qiao, Jie
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 25 February 2025
First Online: 4 March 2025
Competing interests
: Yi Liu is a professor of bioscience at Hubei university, and a scientific advisor to BravoVax. The regents of Hubei University and BravoVax have one patent pending for CRISPR-Cas12a detection technologies on which professor Yi Liu and Jie Qiao are inventors. The remaining authors declare no competing interests.
